U.S. flag

An official website of the United States government

NM_017739.4(POMGNT1):c.1457G>A (p.Arg486Gln) AND multiple conditions

Germline classification:
not provided (1 submission)
Review status:
no classification provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001535608.2

Allele description [Variation Report for NM_017739.4(POMGNT1):c.1457G>A (p.Arg486Gln)]

NM_017739.4(POMGNT1):c.1457G>A (p.Arg486Gln)

Genes:
POMGNT1:protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) [Gene - OMIM - HGNC]
TSPAN1:tetraspanin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.1
Genomic location:
Preferred name:
NM_017739.4(POMGNT1):c.1457G>A (p.Arg486Gln)
HGVS:
  • NC_000001.11:g.46192180C>T
  • NG_009205.3:g.33126G>A
  • NM_001243766.2:c.1457G>A
  • NM_001290129.2:c.1391G>A
  • NM_001290130.2:c.1028G>A
  • NM_017739.4:c.1457G>AMANE SELECT
  • NP_001230695.2:p.Arg486Gln
  • NP_001277058.2:p.Arg464Gln
  • NP_001277059.2:p.Arg343Gln
  • NP_060209.3:p.Arg486Gln
  • NP_060209.4:p.Arg486Gln
  • LRG_701t1:c.1457G>A
  • LRG_701t2:c.1457G>A
  • LRG_701:g.33126G>A
  • LRG_701p1:p.Arg486Gln
  • LRG_701p2:p.Arg486Gln
  • NC_000001.10:g.46657852C>T
  • NG_009205.2:g.33126G>A
  • NM_017739.3:c.1457G>A
Protein change:
R343Q
Links:
dbSNP: rs753030030
NCBI 1000 Genomes Browser:
rs753030030
Molecular consequence:
  • NM_001243766.2:c.1457G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001290129.2:c.1391G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001290130.2:c.1028G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_017739.4:c.1457G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Autosomal recessive limb-girdle muscular dystrophy type 2O
Synonyms:
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED; Limb-Girdle Muscular Dystrophy Type 3C; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0013161; MedGen: C3150417; Orphanet: 206564; OMIM: 613157
Name:
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 (MDDGB3)
Synonyms:
MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 3
Identifiers:
MONDO: MONDO:0013155; MedGen: C3150412; OMIM: 613151
Name:
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
Synonyms:
WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMGNT1-RELATED; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3; Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3
Identifiers:
MONDO: MONDO:0009667; MedGen: C3151519; OMIM: 253280

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001749625GenomeConnect - Invitae Patient Insights Network
no classification provided
not providedunknownphenotyping only

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedphenotyping only

Details of each submission

From GenomeConnect - Invitae Patient Insights Network, SCV001749625.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedphenotyping onlynot provided

Description

Variant interpreted as Uncertain significance and reported on 11-27-2017 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024